Objectives: Seeding prosthetic grafts with fat-derived microvascular endothelial cells (MVEC) results not only in a nonthrombogenic EC layer, but also in intimal hyperplasia. Here we investigated incidence, composition, progression, and cause of this intimal hyperplasia.
Introduction
Seeding autologous endothelial cells onto prosthetic small diameter bypasses has been developped to improve patency. 1 This technique has been studied extensively over the past years with vein-derived EC. Initial results were disappointing as the number of cells harvested appeared to be too low to cover grafts confluently. First culturing the cells and subsequently implantating the seeded graft in a second procedure, resulted in favorable outcomes in animal models [2] [3] [4] and in humans. [5] [6] [7] Due to the need for cell culture, however, it fails to become popular among vascular surgeons. Culture makes the procedure unsuitable for urgent cases, cells may grow poorly or may become contaminated, and the procedure is expensive. 5 For this reason investigators have looked for other sources of EC. Our group first investigated the possibility of using mesothelial cells (MC) as an alternative for EC. Despite hopeful in vitro results, final in vivo experiments showed that these cells did not have the desired antithrombogenic and fibrinolytic properties. 8 Subcutaneous fat tissue was found to be a source of large amounts of microvascular endothelial cells (MVEC). 9 In vitro experiments with cultured cells, statically and under blood flow conditions showed expecting results. 10, 11 Via a pressure sodding technique, MVEC can be inserted directly into the crevices of polymeric grafts, 9 resulting in a graft ready for implantation within a few minutes. In dogs, MVEC sodding of small diameter expanded polytetrafluoroethylene (ePTFE) vascular grafts resulted in a statistically significant improvement in graft patency. 9, 12 So far only a limited amount of human studies have been published [13] [14] [15] with quite disappointing results. 13, 15 The few samples available for histologic evaluation showed EC on top of a progressively concentric intimal thickening. 13, 14 Intimal hyperplasia has also been found in dogs, 9, 12 but seems to expand more progressively in humans, 13, 14 ultimately leading to graft occlusion. Aim of this study was to investigate specific characteristics of this MVEC seeding related intimal hyperplasia, such as the incidence, composition and progression in time, and the contribution of the seeded cells.
Methods

Design of the study
EPTFE grafts with falciform derived MVEC were implanted as carotid interpositions in dogs. A We studied the incidence and composition of the intimal hyperplasia, using six dogs with a follow-up of 1 month. B Three more dogs with a follow up of 4, 8 and 12 months were used to investigate the progression in one year. C To determine whether the seeded cells contribute to the intimal hyperplasia, genetically marked MVEC were seeded in three additional dogs. Follow up was 2 weeks for one and 3 weeks for the other two dogs. Acetylsalicylic acid, 80 mg a day starting one week before the experiment, was given the first month to prevent platelet aggregation. 9 The three dogs whose cells were genetically marked before seeding were also given immunosuppression, azathioprine, 25-50 mg a day starting one week after implantation of the grafts, as expression of marker peptides on the cell surface results in the development of cytotoxic T-cells. 16 All grafts were implanted as paired grafts, where one graft served as a control. The relation of intimal hyperplasia to MVEC seeding could be established by implantation a nonseeded graft on the other side. Possible differences in cell behaviour due to genetic marking and immunosuppression could be demonstrated by implantation a graft seeded with non-labelled cells on the other side.
Animal care
Animal experiments were approved by the ethics committee of the University of Utrecht. The animal care complied with the Guide for the Care and Use of Laboratory Animals, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Washington: National Academy Press, 1996. Twelve mongrel dogs, weighing 10-40 kg, were used.
Anaesthesia
All surgical procedures were carried out as described before. 8 Just before the first incision, antibiotics (amoxicilline) were administered, and just before clamping of the vessels, heparin (100 IE/kg) was given, both i.v.
Isolation of microvascular endothelial cells
MVEC were isolated from the falciform ligament. 9 Amounts of fat were incubated for 30 min at 37°C under continuous vigorous shaking with equal volumes of crude collagenase obtained from Clostridium histolyticum (Sigma-Aldrich Chemie, Steinheim, Germany) (0.4% w/v), BSA (Sigma) (0.4% w/v) in Phosphate Buffered Saline (PBS), pH 7.4. The digested fat was sieved and centrifuged (1200 rpm; 12 min; room temperature (RT)). The pellets were resuspended in Medium 199 (Gibco BRL, Life Technologies, Paisley, Scotland). The cellsuspension was centrifuged again (1100 rpm; 5 min; RT) and the pellet was resuspended in sodding medium (Medium 199 with autologous serum in a ratio of 6:1). The cells used immediately for seeding were suspended to a concentration of 2x10 5 cells/cm 2 of graft surface. The cells used for identification were seeded in a concentration of 1x10 5 cells/cm 2 on fibronectin-coated glass coverslips. The cells used for of genetic labeling were seeded in the same concentration on Retronectin®-coated (Takara Biomedical Group, Shuzo Co, Shigo, Japan) non-tissue-culture-treated plates.
Identification of isolated cells
MVEC were cultured in EBM-MV2 Bulletkit culture medium (Clonetics, BioWhittaker, Verviers, Belgium)/ 0.5 µM dibutyryl cAMP (Sigma). After confluence, cells were fixed with 3.5% paraformaldehyde (PFA)/ 0.1% Tween. Stains were performed with sheep anti-canine von Willebrand Factor (vWF) (Kordia, Leiden, The Netherlands), mouse anti-human α-actin (DAKO, Glostryp, Denmark), mouse anti-human vimentin (DAKO) and for visualization FITC-conjugated goat anti-mouse antibody (Becton and Dickinson, Bedford, Mass., USA) or -rabbit anti-sheep antibody (DAKO). Incubations were done for 45 min at 37°C, followed by three wash-steps of 10 min. Cells were visualized with confocal laser microscope (Leica TCS nt, Leica, Heidelberg, Germany).
Retroviral gene transduction of isolated cells
We used retroviral gene transduction, gene delivery via a replication deficient retrovirus, to tag cells with a marker gene which is readily detectable. 17 No species-specific canine marker was available, therefore we initially employed the widely-used green fluorescent protein (GFP) marker. Because of autofluorescence of the prosthesis, GFP fluorescence was difficult to detect and a GFP-specific antibody was used. Cells of another two dogs were transduced with truncated low affinity nerve growth factor receptor (LNGFR), a human receptor. Two days before start of the transduction, producer cells (Phoenix-GFP, titer 1-2x10 6 or Frapé-1, 1x10 7 IU/ml) were plated in different concentrations. 17 After 24h, producer cells with the highest concentration were covered with EBM-MV2 Bulletkit culture medium without hydrocortison. The next day this MVEC-medium was harvested, filtered, and after addition of cAMP and hydrocortison, applied to the MVEC. Transductions were repeated for four and three successive days in case of GFP-and LNGFR-transduction, respectively. One week after isolation transduced and mock(non)-transduced cells were trypsinized, washed and resuspended for seeding as mentioned above. 
Graft preparing and sodding
Standard ePTFE grafts (8 cm length, 4 mm diameter, 30 µm fibril length; generous gift from WL Gore & Associates, Flagstaff, Arizona, USA) were used. On both ends luerlock connectors were attached. Half an hour before MVEC-sodding, the grafts were filled under pressure, one end closed, with sodding medium to replace trapped air in the interstices of the graft. The cell suspension was introduced into the graft with a lumbar puncture needle, from bottom to top. Subsequently, a syringe filled with sodding medium, four times the volume of the prosthesis, was attached to the luerlock connector. The medium was pressed through the graft in about 1 to 2 minutes. Earlier experiments with a pressure gauge mounted in the system, had shown that so the necessary pressure of 5 pounds per square inch (psi) was obtained and maintained. 9 
Graft implantation
Graft implantation was performed as described before. 8 A 3 to 4 cm piece was removed and, to match the retraction, a 5 cm graft was implanted.
Assessment of graft patency
The patency of the grafts during follow-up was assessed in three ways. A Doppler investigation was done, for the first 9 dogs after 1 and 4 weeks and then once a month, for the 3 dogs of the transduction experiment weekly. Selective angiography was performed of all dogs with a follow-up of one month and of the dog with a follow-up of 12 months, just prior to explantation. In all dogs, an incision was made in the native artery distal to the graft after more distal cross-clamping, just before termination.
Graft explantation
Graft explantation was performed as described before. 8 The grafts were fixed for histology and scanning electron microscopy (SEM).
Scanning electron microscopy
Sections of the graft were prepared as described before, 8 and examined with a scanning electron microscope (Philips, Eindhoven, The Netherlands).
Histopathology and immunohistochemistry
Paraffin slides were made. Haematoxylin and eosin (HE), elastic von Gieson (EvG) and immunohistochemical stains were performed. For each dog the intimal thickness was determined as follows: For every graft, 4 cross sections were taken at a distance of 0.3 cm. For every cross section, at a regular distance of 300 µm, the thickness was measured. For every cross section, 32 measurements were obtained. The cell density in the hyperplastic intima was determined by counting nuclei in circumscribed areas of the same cross sections (4 measurements/cross section). Measurements were performed with a light microscope equipped with a JAC-CCD camera (Copenhagen, Denmark) coupled to a matrox frame grabber (Matrox Electronic systems Ltd., Quebec, Canada) using Optimas 6.0 software (DVS, Breda, The Netherlands). Immunohistochemical stainings were preceded by endogenous peroxidase blocking and citrate boiling, or Triton-serum blocking as in the case of GFPand LNGFR-staining. Endogenous peroxidase blocking was performed with 1.5% H 2 O 2 in phosphate-citrate buffer (citric acid mono-hydrate 8.32 g/l, Na 2 HPO 4 21.52 g/l; pH 5.8±0.1) for 15 min. Citrate boiling was done in citrate buffer (Na 3 citrate dihydrate 2.94 g/l; pH 6.0) for 10 min. Triton-serum blocking was done with 0.4% Triton X-100/5% horse serum in PBS for 1 hour. As primary antibodies sheep anti-canine vWF, mouse anti-human α-actin, mouse anti-human vimentin, mouse anti-GFP (Clonetech Laboratories, Palo Alto, CA, USA), mouse anti-human LNGFR and mouse anti-human CD3 (DAKO) were used. Peroxidase/DAB stainings were done with Vectastain Elite ABC Kit and DAB kit for peroxidase staining (Vector Laboratories, Burlingame, CA, USA), according to the manufactures' recommendations.
Statistical analysis
Results are presented as the median (1 st -3 rd quartile range). fig. 1a-c) .
Results
Isolation and identification of microvascular endothelial cells
A. Incidence and composition of intimal hyperplasia after one month of follow-up
Patency: All of the grafts were palpated and found to be open just prior to closure of the wound. In one dog no doppler signals were found on both sides after one week, while in the other five dogs bilateral doppler sounds remained present until the end of the follow-up. Angiography at termination showed bilateral occlusion in the dog without doppler signals. All other grafts were patent without any signs of stenosis. No angiographic difference existed between the MVEC sodded grafts and the controls. Macroscopic examination at the time of explantation showed that the occluded grafts had a bluish color representative of thrombus, no pulsations were present. The other grafts had a white color and clear pulsations. Histopathology: All patent seeded grafts were covered with a neointima, consisting of an intact cell monolayer, with characteristics of EC, on top of a multilayer of cells and fibers ( fig. 2a) . The fibers present in the intima were identified as collagen and elastin ( fig. 2b) . The neointima found in all patent seeded grafts showed a variable thickness in axial as well as transversal direction. The intimal thickness was 143 (116-152) µm and the cell density 2.9 (2.9-4.1) x10 3 /mm 2 (table 1). All patent nonseeded grafts showed a covering consisting of fibrin and platelets. Both occluded grafts, the MVEC sodded and the control, were filled with a thrombus consisting of platelets and fibrin. SEM: The patent seeded grafts were covered with a smooth confluent cell layer with EC-morphology. No fibrin formation was seen, nor signs of platelet aggregates. The occluded grafts and all nonseeded patent grafts showed activation of coagulation (fibrin and platelet deposition). No endothelialization was present in the patent nonseeded grafts except for the peri-anastomotic pannus. Immunohistochemistry: Cells present in the inner monolayer of the neointima which covered all patent seeded grafts were all vimentin-and vWF-positive, identifying them as EC ( fig. 2c,e) . Cells present in the multilayer between the monolayer of EC and the prosthesis were all vimentin-and α-actin-positive, classifying them as myofibroblasts ( fig. 2d,e) . were not available (n.a.), due to occlusion of the sodded grafts.
B. Changes in thickness and composition of the neointima during a follow-up of 12 months
Patency: Immediately after implantation, the grafts in the three dogs with a follow-up of 4, 8 and 12 months, respectively, were palpated and found to be open. At the time of explantation two of the three seeded grafts were patent. All non-seeded ones and the seeded one with a follow-up of 8 months were occluded ( fig. 3 ). Doppler investigation showed that the occlusions had occurred between 1 and 4 weeks of follow-up. Angiography of the dog with a follow-up of 12 months showed a patent seeded graft without any signs of stenosis and an occluded nonseeded graft.
Histopathology:
The patent seeded grafts with a follow-up of 4 and 12 months showed an intact cell monolayer, with characteristics of EC, covering a multilayer of cells and fibers ( fig. 2a,b) . The intimal thicknesses after 4 and 12 months were 21 (6-93) µm and 21 (9-47) µm, and the cell densities were 3.6 (2.9-5.1)x10 3 /mm 2 and 1.7 (0.6-2.2)x10 3 /mm 2 , respectively (table 1) . No differences were found in identity of fibers between a follow-up of one month and the longer follow-ups of 4 and 12 months ( fig. 2b ). Simular to one month of follow up, a variable thickness in axial as well as transversal direction was found. All nonseeded grafts and the graft with a follow-up of 8 months were occluded with an organized thrombus, consisting of connective tissue, cells and microvessels. SEM: Again, the patent seeded grafts were covered with a smooth confluent cell layer with EC-morphology, without deposition of fibrin and platelet aggregates. Immunohistochemistry: No differences were found in identity of cells between follow-up of one month and the longer follow-ups of 4 and 12 months ( fig. 2c-e) . 
C. Contribution of the seeded cells to the intimal hyperplasia
Transduction efficiency: Transduction efficiency of the GFP-transduced cells was 35% ( fig. 4a') , while the transduction efficiency of the LNGFR-transduced cells was 80% (75-85%) ( fig. 4b' ). fig. 4c ), but not in mock-transduced grafts. This Tcell infiltrate was less abundantly present in the graft with a follow-up of 2 weeks than in the grafts with a follow-up of 3 weeks. The infiltrate was not present in the grafts sodded with mock-transduced cells.
Discussion
Seeding of venous EC has been used to increase the patency of prosthetic grafts. Although the results were satisfactory, the technique did not find general acceptance. The mean reason is that low yield of EC from veins makes cell culture necessary. To avoid problems due to cell culture, alternative cells and sources for EC have been explored. Subcutaneous fat has been introduced as a source of large numberss of MVEC, 9-11 being able to form a nonthrombogenic luminal EC layer in vivo. A fat-derived MVEC seeding related problem, however, is the development of a thickened intima, which can result in occlusion of the graft. The intimal hyperplasia found after seeding of MVEC is much more extensive than after seeding of more pure vein-derived EC, both in humans, 18 and in other species. 3 An until now unproven suggestion is that the neointima, found after seeding of MVEC, exists of cells seeded on the graft as impurities of the transplant. 5, 12 Aim of this study was to investigate specific characteristics of MVEC seedingassociated intimal hyperplasia in terms of incidence, composition, and progression in time, and the contribution of the seeded cells. We found that MVEC, isolated from the falciform ligament, consisted of a combination of EC, fibroblasts and myofibroblasts. In all patent seeded grafts a confluent EC lining as well as intimal hyperplasia was present. The thickened intima consisted of a multilayer of myofibroblasts, elastin and collagen. Thickness and cell density of the intima did not progress after one month. All patent non-seeded grafts were covered with platelets and fibrin and did not show any intimal hyperplasia. After marking the seeded cells we found that the transplanted cells were present in the EC monolayer, the intima, and the luminal part of the prosthesis.
Here we have shown for the first time that contaminants of the transplant contribute to MVEC seeding related intimal hyperplasia. Using a fluorescent dye, it has been shown that after 3 weeks of follow up, EC lining prosthetic grafts originate from the seeded cells. 19 In another study no evidence was found, however, for the hypothesis that intima formation is due to seeded cells. 20 The differences compared to our study were that the seeding density was much lower than the recommended density we used; 6,9 that the polyester used was more porous and such more easily populated from the surrounding tissue; 20 and that venous EC were used which are more pure than MVEC. Retroviral transduction did not affect the results of cell seeding, as could be established by using a graft sodded with non-labelled cells as a control. Furthermore the immunosuppression, given to the dogs of the transduction experiment, did not affect the structure of the EC-layer and intimal hyperplasia present on the grafts. No differences existed compared to the EC-layer and intimal hyperplasia present on the seeded grafts of both other experiments without immunosuppression. Not all cells present in the EC monolayer, intima and inner third of the prosthesis expressed the marker. The transduction efficiency was not 100%, besides the transduced cells can be destroyed by cytotoxic T-cells present, despite immunosuppression. Furthermore we can not exclude the contribution of cells coming from both vessel ends or from tissue around the prosthesis. The contribution of these endogenous cells is higher, however, when a very porous prosthesis is used than when a less porous prosthesis is used, as we did in our study. 20 Although it is possible that the positive myofibroblasts present in the intima are transdifferentiated MVEC, it is most likely that the positive myofibroblasts are contaminants from the transplant. First, fibroblast-like cells are present in isolates of canine fat-derived MVEC. Second, a neointima forms less extensively after the seeding of vein-derived EC, which contain less contaminating cells. 3, 4 And third, single cell culture studies have shown that although certain cell types (e.g. interstitial EC from heart valves) can transdifferentiate, human umbilical cord EC and dermal MVEC cannot. 21, 22 The myofibroblasts present in the neointima showed other characteristics than the impurities present in the transplants, because they stained all positive for α-actin. The expression of myofibroblast-specific characteristics can be induced by the surroundings, as a time-dependent maturation of myofibroblasts present in the neointima has been found. 23 Immediately after implantation cells resemble fibroblasts, afterwards they gradually change into smooth muscle cells with an increased expression of α-actin. 12 As mentioned before, 24 all thickened intimas showed a variable thickness in axial as well as transversal cross-section, which might be explained by variations in bloodflow, 25 density of graft material, or velocity of the formation of a confluent EC layer. 26, 27 From the present study we conclude that contaminants from the transplant contribute to intimal hyperplasia associated with microvascular endothelial cell seeding. Further purification of fat-derived MVEC should reduce intimal hyperplasia. Hopefully, this will lead to a smaller degree of stenosis and thrombosis and improve results of MVEC seeded grafts used for bypass and other vascular surgery.
